Template:Percutaneous Coronary Intervention: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
No edit summary
Line 73: Line 73:


:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in Specific Clinical Situations|PCI in Specific Clinical Situations:]]
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in Specific Clinical Situations|PCI in Specific Clinical Situations:]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With Asymptomatic Ischemia or CCS Class I or II Angina|PCI in patients with Asymptomatic Ischemia or CCS Class I or II Angina]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With CCS Class III Angina|PCI in patients with CCS Class III Angina]]


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction|PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction|PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction]]
Line 82: Line 86:
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Primary PCI of the Infarct Artery|Primary PCI of the Infarct Artery]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Primary PCI of the Infarct Artery|Primary PCI of the Infarct Artery]]


:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Delayed or Elective PCI in patients with STEMI|Delayed or Elective PCI in patients with STEMI]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Delayed or Elective PCI in Patients with STEMI|Delayed or Elective PCI in patients with STEMI]]
 
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With STEMI: General and Specific Considerations|STEMI: General and Specific Considerations]]
 
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in Fibrinolytic-Ineligible Patients|PCI in Fibrinolytic-Ineligible Patients]]
 
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Facilitated PCI|Facilitated PCI]]
 
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Rescue PCI (PCI After Failed Fibrinolysis)|Rescue PCI]]
 
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion|PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]]


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Cardiogenic Shock|PCI in patients with Cardiogenic Shock]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Cardiogenic Shock|PCI in patients with Cardiogenic Shock]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Prior Coronary Bypass Surgery|PCI in patients with Prior Coronary Bypass Surgery]]


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Revascularization Before Non-cardiac Surgery|Revascularization Before Non-cardiac Surgery]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Revascularization Before Non-cardiac Surgery|Revascularization Before Non-cardiac Surgery]]
Line 90: Line 106:
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Stents|Coronary Stents]]
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Stents|Coronary Stents]]


:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Adjunctive Diagnostic Devices|Adjunctive Diagnostic Devices:]]
:Adjunctive Diagnostic Devices:
 
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Fractional Flow Reserve|Fractional Flow Reserve]]
 
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravascular Ultrasound|Intravascular Ultrasound]]
 
:Adjunctive Therapeutic Devices:


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Atherectomy|Coronary Atherectomy]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Atherectomy|Coronary Atherectomy]]
Line 102: Line 124:
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Embolic Protection Devices|Embolic Protection Devices]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Embolic Protection Devices|Embolic Protection Devices]]


:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Percutaneous Hemodynamic Support Devices|Percutaneous Hemodynamic Support Devices:]]
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Percutaneous Hemodynamic Support Devices|Percutaneous Hemodynamic Support Devices]]
 
:Antiplatelet Therapy:


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Oral Antiplatelet Therapy|Oral Antiplatelet Therapy]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Oral Antiplatelet Therapy|Oral Antiplatelet Therapy]]


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy|Intravenous Antiplatelet Therapy:]]
::Intravenous Antiplatelet Therapy:


:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy in patients with ST-Elevation Myocardial Infarction|STEMI]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy: ST-Elevation Myocardial Infarction (STEMI)|STEMI]]


:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy in patients with Unstable Angina/Non-ST Elevation Myocardial Infarction|UA/NSTEMI]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy: Unstable Angina / Non-ST Elevation Myocardial Infarction (UA/NSTEMI)|UA/NSTEMI]]


:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy in patients with Stable Ischemic Heart Disease (SIHD)|SIHD]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy: Sudden Ischemia Heart Disease (SIHD)|SIHD]]


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Anticoagulant Therapy|Anticoagulant Therapy:]]
:Anticoagulant Therapy:


:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Use of Parenteral Anticoagulants During PCI|Parenteral Anticoagulants During PCI]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Use of Parenteral Anticoagulants during PCI|Parenteral Anticoagulants During PCI]]


:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Unfractionated Heparin|Unfractionated Heparin]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Unfractionated Heparin|Unfractionated Heparin]]
Line 122: Line 146:
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Enoxaparin|Enoxaparin]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Enoxaparin|Enoxaparin]]


:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Bivalirudin and Argatroban|Bivalirudin and Argatroban]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Bivalirudin and Argatoban|Bivalirudin and Argatroban]]


:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Fondaparinux|Fondaparinux]]
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Fondaparinux|Fondaparinux]]
Line 128: Line 152:
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#No-Reflow Pharmacological Therapies|No-Reflow Pharmacological Therapies]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#No-Reflow Pharmacological Therapies|No-Reflow Pharmacological Therapies]]


:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in Specific Anatomic Situations|PCI in Specific Anatomic Situations:]]
:PCI in Specific Anatomic Situations:


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Total Occlusions|Chronic Total Occlusions]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Total Occlusions|Chronic Total Occlusions]]
Line 140: Line 164:
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Calcified Lesions|Calcified Lesions]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Calcified Lesions|Calcified Lesions]]


:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in Specific Patient Populations|PCI in Specific Patient Populations:]]
:PCI in Specific Patient Populations:


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Kidney Disease|Chronic Kidney Disease]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Kidney Disease|Chronic Kidney Disease]]


:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Periprocedural Myocardial Infarction Assessment|Periprocedural Myocardial Infarction Assessment]]
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Peri-procedural Myocardial Infarction Assessment|Peri-procedural Myocardial Infarction Assessment]]


:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Vascular Closure Devices|Vascular Closure Devices]]
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Vascular Closure Devices|Vascular Closure Devices]]
Line 156: Line 180:
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Post-procedural Antiplatelet Therapy|Post-procedural Antiplatelet Therapy:]]
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Post-procedural Antiplatelet Therapy|Post-procedural Antiplatelet Therapy:]]


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Proton Pump Inhibitors and Antiplatelet Therapy|Proton Pump Inhibitors and Antiplatelet Therapy]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Proton Pump Inhibitors and Anti-platelet Therapy|Proton Pump Inhibitors and Antiplatelet Therapy]]


::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Clopidogrel Genetic Testing|Clopidogrel Genetic Testing]]
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Clopidogrel Genetic Testing|Clopidogrel Genetic Testing]]

Revision as of 16:59, 19 December 2011

Percutaneous Coronary Intervention Microchapters

Home

Patient Info

Guideline Recommendations

CAD Revascularization:

Heart Team Approach to Revascularization Decisions
Left Main Coronary Artery Disease
Non-Left Main Coronary Artery Disease
Revascularization to Improve Symptoms
Dual Antiplatelet Therapy Compliance and Stent Thrombosis
Hybrid Coronary Revascularization

Pre-procedural Considerations:

Radiation Safety
Contrast-Induced Acute Kidney Injury
Anaphylactoid Reactions
Statin Treatment
Bleeding Risk
Role of Onsite Surgical Backup:
Primary PCI in Hospitals Without On-Site Surgical Backup
Elective PCI in Hospitals Without On-Site Surgical Backup

Procedural Considerations:

Vascular Access
PCI in Specific Clinical Situations:
PCI in patients with Asymptomatic Ischemia or CCS Class I or II Angina
PCI in patients with CCS Class III Angina
PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction
PCI in patients with ST-Elevation Myocardial Infarction
Coronary Angiography Strategies in STEMI
Primary PCI of the Infarct Artery
Delayed or Elective PCI in patients with STEMI
STEMI: General and Specific Considerations
PCI in Fibrinolytic-Ineligible Patients
Facilitated PCI
Rescue PCI
PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
PCI in patients with Cardiogenic Shock
PCI in patients with Prior Coronary Bypass Surgery
Revascularization Before Non-cardiac Surgery
Coronary Stents
Adjunctive Diagnostic Devices:
Fractional Flow Reserve
Intravascular Ultrasound
Adjunctive Therapeutic Devices:
Coronary Atherectomy
Thrombectomy
Laser Angioplasty
Cutting Balloon Angioplasty
Embolic Protection Devices
Percutaneous Hemodynamic Support Devices
Antiplatelet Therapy:
Oral Antiplatelet Therapy
Intravenous Antiplatelet Therapy:
STEMI
UA/NSTEMI
SIHD
Anticoagulant Therapy:
Parenteral Anticoagulants During PCI
Unfractionated Heparin
Enoxaparin
Bivalirudin and Argatroban
Fondaparinux
No-Reflow Pharmacological Therapies
PCI in Specific Anatomic Situations:
Chronic Total Occlusions
Saphenous Vein Grafts
Bifurcation Lesions
Aorto-Ostial Stenoses
Calcified Lesions
PCI in Specific Patient Populations:
Chronic Kidney Disease
Peri-procedural Myocardial Infarction Assessment
Vascular Closure Devices

Post-Procedural Considerations:

Post-procedural Antiplatelet Therapy:
Proton Pump Inhibitors and Antiplatelet Therapy
Clopidogrel Genetic Testing
Platelet Function Testing
Restenosis:
Exercise Testing
Cardiac Rehabilitation

Quality and Performance Considerations:

Quality and Performance
Certification and Maintenance of Certification
Operator and Institutional Competency and Volume

Percutaneous Coronary Intervention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Percutaneous Coronary Intervention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Percutaneous Coronary Intervention

CDC on Percutaneous Coronary Intervention

Percutaneous Coronary Intervention in the news

Blogs on Percutaneous Coronary Intervention

Directions to Hospitals Treating Percutaneous Coronary Intervention

Risk calculators and risk factors for Percutaneous Coronary Intervention

Retrieved from "https://www.wikidoc.org/index.php?title=Template:Percutaneous_Coronary_Intervention&oldid=618502"